29 June 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Cancer Therapy
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly cited papers on cancer therapy research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
"STING Agonists as Cancer Therapeutics"
by Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus and Jason J. Luke
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695
Available online: https://www.mdpi.com/2072-6694/13/11/2695
"MMP9: A Tough Target for Targeted Therapy for Cancer"
by Katarzyna Augoff, Anita Hryniewicz-Jankowska, Renata Tabola and Kamilla Stach
Cancers 2022, 14(7), 1847; https://doi.org/10.3390/cancers14071847
Available online: https://www.mdpi.com/2072-6694/14/7/1847
"Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives"
by Nora Berois, Alvaro Pittini and Eduardo Osinaga
Cancers 2022, 14(3), 645; https://doi.org/10.3390/cancers14030645
Available online: https://www.mdpi.com/2072-6694/14/3/645
"The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment"
by Keiko Taguchi and Masayuki Yamamoto
Cancers 2021, 13(1), 46; https://doi.org/10.3390/cancers13010046
Available online: https://www.mdpi.com/2072-6694/13/1/46
"Photodynamic Therapy: A Compendium of Latest Reviews"
by José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, Luís Rodríguez-Cobo and José Miguel López-Higuera
Cancers 2021, 13(17), 4447; https://doi.org/10.3390/cancers13174447
Available online: https://www.mdpi.com/2072-6694/13/17/4447
"Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives"
by Cristina Birzu, Pim French, Mario Caccese, Giulia Cerretti, Ahmed Idbaih, Vittorina Zagonel and Giuseppe Lombardi
Cancers 2021, 13(1), 47; https://doi.org/10.3390/cancers13010047
Available online: https://www.mdpi.com/2072-6694/13/1/47
"Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives"
by Shirin Hafezi and Mohamed Rahmani
Cancers 2021, 13(6), 1292; https://doi.org/10.3390/cancers13061292
Available online: https://www.mdpi.com/2072-6694/13/6/1292
“Feature Review for Cancer Therapy” |
“Novel Therapeutic Strategies in Salivary Gland Tumor” |
“State-of-the-Art Mechanisms of Drug Resistance to Targeted Therapy in Cancers” |
“New Strategies in Diagnosis and Treatments for Brain Tumors (Volume II)” |
We hope this announcement will provide useful information for this field.